Fish, marine n-3 polyunsaturated fatty acids and coronary heart disease: a minireview with focus on clinical trial data

Erik Berg Schmidt; Lars Hvilsted Rasmussen; Jeppe Grøndahl Rasmussen; Albert Marni Joensen; Martin Bruun Madsen; Jeppe Hagstrup Christensen

doi:10.1016/j.plefa.2006.05.008

Fish, marine n-3 polyunsaturated fatty acids and coronary heart disease: a minireview with focus on clinical trial data

Prostaglandins Leukot Essent Fatty Acids. 2006 Sep;75(3):191-5. doi: 10.1016/j.plefa.2006.05.008. Epub 2006 Jul 17.

Authors

Erik Berg Schmidt¹, Lars Hvilsted Rasmussen, Jeppe Grøndahl Rasmussen, Albert Marni Joensen, Martin Bruun Madsen, Jeppe Hagstrup Christensen

Affiliation

¹ Department of Cardiology, Center for Cardiovascular Research, Aalborg Sygehus, Arhus University Hospitals, Denmark. ebs@dadlnet.dk

PMID: 16844362
DOI: 10.1016/j.plefa.2006.05.008

Abstract

In this paper, we will briefly deal with the background for the possible effects of long-chain marine n-3 (also called omega-3) polyunsaturated fatty acids (PUFA) in coronary heart disease (CHD) and then focus on findings from clinical trials in humans. We will not deal with effects of alpha-linolenic acid, the non-marine type of n-3 PUFA derived from plant oils.

Publication types

Review

MeSH terms

Animals
Clinical Trials as Topic
Coronary Disease / blood
Coronary Disease / diet therapy*
Coronary Disease / prevention & control
Fatty Acids, Omega-3 / administration & dosage*
Fatty Acids, Omega-3 / blood
Fish Oils / administration & dosage
Fish Oils / chemistry
Fishes*
Humans
Risk Factors

Substances

Fatty Acids, Omega-3
Fish Oils